Studies have shown that active fund managers routinely underperform the S&P500 index*​

Boundless Bio, Inc. (NASDAQ: BOLD)

BOLD Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
195.10%

BOLD Stock Analysis

BOLD PE Ratio:

BOLD PEG Ratio: Not Available

BOLD Forward EPS Growth (12 month): 0.00%

BOLD PS Ratio:

BOLD PSG Ratio: Not Available

BOLD Forward Revenue Growth (12 month): 0.00%

BOLD Articles

No data was found